Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing long-term safety and efficacy of fenebrutinib in participants previously enrolled in a CSU study has been terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• Fenebrutinib (Fenebrutinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Urticaria | Phase 2 | Status: TERMINATED | Results posted: 2020-09-25